• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Show Search
Home
EN / FR
  • LinkedIn
  • Twitter
Celyad Oncology

Celyad Oncology

  • About Us
    • Overview
    • Management Team
    • Board Of Directors
    • Scientific Advisory Board
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • TIM
      • shRNA
    • Manufacturing
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Contact Us
    • Careers
Home / Investors / Regulated Information

Regulated Information

Financial Reports

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

24

Mar
2021

Annual Report 2020

FR

EN


22

Mar
2020

Annual Report 2019

FR

EN

07

May
2020

First Quarter 2020 Financial Results and Recent Business Highlights

FR

EN

10

Nov
2020

Third Quarter 2020 Financial Results and Recent Business Highlights

FR

EN


28

Mar
2019

Full Year 2018 Financial and Operating Results

FR

EN

05

Apr
2019

Annual Report 2018

FR

EN

09

May
2019

First Quarter 2019 Financial Results and Recent Business Highlights

FR

EN

22

Aug
2019

Interim Financial Report H1.2019

FR

EN

19

Nov
2019

Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights

FR

EN


22

Mar
2018

Full year 2017 Financial and Operating Results

FR

EN

06

Apr
2018

Annual report 2017

FR

EN

15

May
2018

First Quarter 2018 Financial Results and Recent Business Highlights

FR

EN

23

Aug
2018

First Half 2018 Financial Results and Operational Progress

FR

EN


23

Mar
2017

Celyad Reports 2016 Financial and Operating Results

FR

EN

19

May
2017

First Quarter 2017 Business Update

FR

EN

26

May
2017

Celyad’s Annual Report 2016

FR

EN

29

Aug
2017

First Half 2017 Financial statements and operational progress

FR

EN


06

Apr
2016

AR 2015 Annual report

EN

20

May
2016

Q1 2016 Business Update

EN

25

Aug
2016

Celyad 2016 First Half Year Report

FR

EN

18

Nov
2016

Q3 2016 Business Update

FR

EN


30

Jun
2015

H1 2015 Interim Financial Report

FR

EN

19

Nov
2015

Q3 2015 Business Update

FR

EN

SEC Filings

Filter


12345...10...»Last »
Filing Date
Form
Description
Filing Group
Downloads
March 25, 2021

20-F

Annual and Transition Report (foreign private issuer)

Other

PDF
RTF
XLS
HTML
XBRL
February 2, 2021

SC 13G/A

Celyad Oncology Filed by Victory Capital Management INC

PDF
RTF
XLS
HTML
XBRL
January 20, 2021

6-K

Report of foreign issuer

Current reports

PDF
RTF
XLS
HTML
XBRL
January 20, 2021

6-K

Report of Foreign Issuer

Current reports

PDF
RTF
XLS
HTML
XBRL
January 7, 2021

424B5

Prospectus filed pursuant to Rule 424(b)(5)

Other

PDF
RTF
XLS
HTML
XBRL
December 7, 2020

6-K

Report of Foreign Issuer

PDF
RTF
XLS
HTML
XBRL

12345...10...»Last »

Regulated Information

Filter

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Press Releases, Regulated | March 31st, 2021

Read More

Acte Notarié du Conseil d’Administration

Regulated | March 31st, 2021

Read More

Rapport Spécial du Conseil d’Administration

Regulated | March 31st, 2021

Read More
Load More

Footer

  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.
Cookie Policy | Privacy Policy | Terms of Use